Pharma & Healthcare
Global Embolization Particle Market Research Report 2026
- Jan 17, 26
- ID: 687722
- Pages: 116
- Figures: 113
- Views: 8
This report delivers a comprehensive overview of the global Embolization Particle market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Embolization Particle. The Embolization Particle market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Embolization Particle market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Embolization Particle manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Segment by Type
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Embolization Particle manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Embolization Particle sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Embolization Particle market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Embolization Particle manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Segment by Type
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Embolization Particle manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Embolization Particle sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Embolization Particle Market Overview
1.1 Product Definition
1.2 Embolization Particle by Type
1.2.1 Global Embolization Particle Market Value by Type: 2025 vs 2032
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Embolization Particle by Application
1.3.1 Global Embolization Particle Market Value by Application: 2025 vs 2032
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Others
1.4 Global Embolization Particle Market Size Estimates and Forecasts
1.4.1 Global Embolization Particle Revenue 2021–2032
1.4.2 Global Embolization Particle Sales 2021–2032
1.4.3 Global Embolization Particle Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Embolization Particle Market Competition by Manufacturers
2.1 Global Embolization Particle Sales Market Share by Manufacturers (2021–2026)
2.2 Global Embolization Particle Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Embolization Particle Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Embolization Particle, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Embolization Particle, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Embolization Particle, Product Types and Applications
2.7 Global Key Manufacturers of Embolization Particle, Date of Entry into the Industry
2.8 Global Embolization Particle Market Competitive Situation and Trends
2.8.1 Global Embolization Particle Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Embolization Particle Players Market Share by Revenue
2.8.3 Global Embolization Particle Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Embolization Particle Market Scenario by Region
3.1 Global Embolization Particle Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Embolization Particle Sales by Region: 2021–2032
3.2.1 Global Embolization Particle Sales by Region: 2021–2026
3.2.2 Global Embolization Particle Sales by Region: 2027–2032
3.3 Global Embolization Particle Revenue by Region: 2021–2032
3.3.1 Global Embolization Particle Revenue by Region: 2021–2026
3.3.2 Global Embolization Particle Revenue by Region: 2027–2032
3.4 North America Embolization Particle Market Facts & Figures by Country
3.4.1 North America Embolization Particle Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Embolization Particle Sales by Country (2021–2032)
3.4.3 North America Embolization Particle Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Embolization Particle Market Facts & Figures by Country
3.5.1 Europe Embolization Particle Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Embolization Particle Sales by Country (2021–2032)
3.5.3 Europe Embolization Particle Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Embolization Particle Market Facts & Figures by Region
3.6.1 Asia Pacific Embolization Particle Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Embolization Particle Sales by Region (2021–2032)
3.6.3 Asia Pacific Embolization Particle Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Embolization Particle Market Facts & Figures by Country
3.7.1 Latin America Embolization Particle Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Embolization Particle Sales by Country (2021–2032)
3.7.3 Latin America Embolization Particle Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Embolization Particle Market Facts & Figures by Country
3.8.1 Middle East and Africa Embolization Particle Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Embolization Particle Sales by Country (2021–2032)
3.8.3 Middle East and Africa Embolization Particle Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Embolization Particle Sales by Type (2021–2032)
4.1.1 Global Embolization Particle Sales by Type (2021–2026)
4.1.2 Global Embolization Particle Sales by Type (2027–2032)
4.1.3 Global Embolization Particle Sales Market Share by Type (2021–2032)
4.2 Global Embolization Particle Revenue by Type (2021–2032)
4.2.1 Global Embolization Particle Revenue by Type (2021–2026)
4.2.2 Global Embolization Particle Revenue by Type (2027–2032)
4.2.3 Global Embolization Particle Revenue Market Share by Type (2021–2032)
4.3 Global Embolization Particle Price by Type (2021–2032)
5 Segment by Application
5.1 Global Embolization Particle Sales by Application (2021–2032)
5.1.1 Global Embolization Particle Sales by Application (2021–2026)
5.1.2 Global Embolization Particle Sales by Application (2027–2032)
5.1.3 Global Embolization Particle Sales Market Share by Application (2021–2032)
5.2 Global Embolization Particle Revenue by Application (2021–2032)
5.2.1 Global Embolization Particle Revenue by Application (2021–2026)
5.2.2 Global Embolization Particle Revenue by Application (2027–2032)
5.2.3 Global Embolization Particle Revenue Market Share by Application (2021–2032)
5.3 Global Embolization Particle Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sirtex Medical
6.1.1 Sirtex Medical Company Information
6.1.2 Sirtex Medical Description and Business Overview
6.1.3 Sirtex Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sirtex Medical Embolization Particle Product Portfolio
6.1.5 Sirtex Medical Recent Developments/Updates
6.2 Merit Medical
6.2.1 Merit Medical Company Information
6.2.2 Merit Medical Description and Business Overview
6.2.3 Merit Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merit Medical Embolization Particle Product Portfolio
6.2.5 Merit Medical Recent Developments/Updates
6.3 Cook Medical
6.3.1 Cook Medical Company Information
6.3.2 Cook Medical Description and Business Overview
6.3.3 Cook Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Cook Medical Embolization Particle Product Portfolio
6.3.5 Cook Medical Recent Developments/Updates
6.4 BTG Medical
6.4.1 BTG Medical Company Information
6.4.2 BTG Medical Description and Business Overview
6.4.3 BTG Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BTG Medical Embolization Particle Product Portfolio
6.4.5 BTG Medical Recent Developments/Updates
6.5 Boston Scientific Corporation
6.5.1 Boston Scientific Corporation Company Information
6.5.2 Boston Scientific Corporation Description and Business Overview
6.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Boston Scientific Corporation Embolization Particle Product Portfolio
6.5.5 Boston Scientific Corporation Recent Developments/Updates
6.6 Terumo Corporation
6.6.1 Terumo Corporation Company Information
6.6.2 Terumo Corporation Description and Business Overview
6.6.3 Terumo Corporation Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Terumo Corporation Embolization Particle Product Portfolio
6.6.5 Terumo Corporation Recent Developments/Updates
6.7 HENGRUI Medical
6.7.1 HENGRUI Medical Company Information
6.7.2 HENGRUI Medical Description and Business Overview
6.7.3 HENGRUI Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 HENGRUI Medical Embolization Particle Product Portfolio
6.7.5 HENGRUI Medical Recent Developments/Updates
6.8 INterface BIOmaterials B.V.
6.8.1 INterface BIOmaterials B.V. Company Information
6.8.2 INterface BIOmaterials B.V. Description and Business Overview
6.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
6.8.5 INterface BIOmaterials B.V. Recent Developments/Updates
6.9 Alicon
6.9.1 Alicon Company Information
6.9.2 Alicon Description and Business Overview
6.9.3 Alicon Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Alicon Embolization Particle Product Portfolio
6.9.5 Alicon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Embolization Particle Industry Chain Analysis
7.2 Embolization Particle Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Embolization Particle Production Mode & Process Analysis
7.4 Embolization Particle Sales and Marketing
7.4.1 Embolization Particle Sales Channels
7.4.2 Embolization Particle Distributors
7.5 Embolization Particle Customer Analysis
8 Embolization Particle Market Dynamics
8.1 Embolization Particle Industry Trends
8.2 Embolization Particle Market Drivers
8.3 Embolization Particle Market Challenges
8.4 Embolization Particle Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Embolization Particle by Type
1.2.1 Global Embolization Particle Market Value by Type: 2025 vs 2032
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Embolization Particle by Application
1.3.1 Global Embolization Particle Market Value by Application: 2025 vs 2032
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Others
1.4 Global Embolization Particle Market Size Estimates and Forecasts
1.4.1 Global Embolization Particle Revenue 2021–2032
1.4.2 Global Embolization Particle Sales 2021–2032
1.4.3 Global Embolization Particle Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Embolization Particle Market Competition by Manufacturers
2.1 Global Embolization Particle Sales Market Share by Manufacturers (2021–2026)
2.2 Global Embolization Particle Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Embolization Particle Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Embolization Particle, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Embolization Particle, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Embolization Particle, Product Types and Applications
2.7 Global Key Manufacturers of Embolization Particle, Date of Entry into the Industry
2.8 Global Embolization Particle Market Competitive Situation and Trends
2.8.1 Global Embolization Particle Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Embolization Particle Players Market Share by Revenue
2.8.3 Global Embolization Particle Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Embolization Particle Market Scenario by Region
3.1 Global Embolization Particle Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Embolization Particle Sales by Region: 2021–2032
3.2.1 Global Embolization Particle Sales by Region: 2021–2026
3.2.2 Global Embolization Particle Sales by Region: 2027–2032
3.3 Global Embolization Particle Revenue by Region: 2021–2032
3.3.1 Global Embolization Particle Revenue by Region: 2021–2026
3.3.2 Global Embolization Particle Revenue by Region: 2027–2032
3.4 North America Embolization Particle Market Facts & Figures by Country
3.4.1 North America Embolization Particle Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Embolization Particle Sales by Country (2021–2032)
3.4.3 North America Embolization Particle Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Embolization Particle Market Facts & Figures by Country
3.5.1 Europe Embolization Particle Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Embolization Particle Sales by Country (2021–2032)
3.5.3 Europe Embolization Particle Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Embolization Particle Market Facts & Figures by Region
3.6.1 Asia Pacific Embolization Particle Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Embolization Particle Sales by Region (2021–2032)
3.6.3 Asia Pacific Embolization Particle Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Embolization Particle Market Facts & Figures by Country
3.7.1 Latin America Embolization Particle Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Embolization Particle Sales by Country (2021–2032)
3.7.3 Latin America Embolization Particle Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Embolization Particle Market Facts & Figures by Country
3.8.1 Middle East and Africa Embolization Particle Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Embolization Particle Sales by Country (2021–2032)
3.8.3 Middle East and Africa Embolization Particle Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Embolization Particle Sales by Type (2021–2032)
4.1.1 Global Embolization Particle Sales by Type (2021–2026)
4.1.2 Global Embolization Particle Sales by Type (2027–2032)
4.1.3 Global Embolization Particle Sales Market Share by Type (2021–2032)
4.2 Global Embolization Particle Revenue by Type (2021–2032)
4.2.1 Global Embolization Particle Revenue by Type (2021–2026)
4.2.2 Global Embolization Particle Revenue by Type (2027–2032)
4.2.3 Global Embolization Particle Revenue Market Share by Type (2021–2032)
4.3 Global Embolization Particle Price by Type (2021–2032)
5 Segment by Application
5.1 Global Embolization Particle Sales by Application (2021–2032)
5.1.1 Global Embolization Particle Sales by Application (2021–2026)
5.1.2 Global Embolization Particle Sales by Application (2027–2032)
5.1.3 Global Embolization Particle Sales Market Share by Application (2021–2032)
5.2 Global Embolization Particle Revenue by Application (2021–2032)
5.2.1 Global Embolization Particle Revenue by Application (2021–2026)
5.2.2 Global Embolization Particle Revenue by Application (2027–2032)
5.2.3 Global Embolization Particle Revenue Market Share by Application (2021–2032)
5.3 Global Embolization Particle Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sirtex Medical
6.1.1 Sirtex Medical Company Information
6.1.2 Sirtex Medical Description and Business Overview
6.1.3 Sirtex Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sirtex Medical Embolization Particle Product Portfolio
6.1.5 Sirtex Medical Recent Developments/Updates
6.2 Merit Medical
6.2.1 Merit Medical Company Information
6.2.2 Merit Medical Description and Business Overview
6.2.3 Merit Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merit Medical Embolization Particle Product Portfolio
6.2.5 Merit Medical Recent Developments/Updates
6.3 Cook Medical
6.3.1 Cook Medical Company Information
6.3.2 Cook Medical Description and Business Overview
6.3.3 Cook Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Cook Medical Embolization Particle Product Portfolio
6.3.5 Cook Medical Recent Developments/Updates
6.4 BTG Medical
6.4.1 BTG Medical Company Information
6.4.2 BTG Medical Description and Business Overview
6.4.3 BTG Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BTG Medical Embolization Particle Product Portfolio
6.4.5 BTG Medical Recent Developments/Updates
6.5 Boston Scientific Corporation
6.5.1 Boston Scientific Corporation Company Information
6.5.2 Boston Scientific Corporation Description and Business Overview
6.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Boston Scientific Corporation Embolization Particle Product Portfolio
6.5.5 Boston Scientific Corporation Recent Developments/Updates
6.6 Terumo Corporation
6.6.1 Terumo Corporation Company Information
6.6.2 Terumo Corporation Description and Business Overview
6.6.3 Terumo Corporation Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Terumo Corporation Embolization Particle Product Portfolio
6.6.5 Terumo Corporation Recent Developments/Updates
6.7 HENGRUI Medical
6.7.1 HENGRUI Medical Company Information
6.7.2 HENGRUI Medical Description and Business Overview
6.7.3 HENGRUI Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 HENGRUI Medical Embolization Particle Product Portfolio
6.7.5 HENGRUI Medical Recent Developments/Updates
6.8 INterface BIOmaterials B.V.
6.8.1 INterface BIOmaterials B.V. Company Information
6.8.2 INterface BIOmaterials B.V. Description and Business Overview
6.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
6.8.5 INterface BIOmaterials B.V. Recent Developments/Updates
6.9 Alicon
6.9.1 Alicon Company Information
6.9.2 Alicon Description and Business Overview
6.9.3 Alicon Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Alicon Embolization Particle Product Portfolio
6.9.5 Alicon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Embolization Particle Industry Chain Analysis
7.2 Embolization Particle Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Embolization Particle Production Mode & Process Analysis
7.4 Embolization Particle Sales and Marketing
7.4.1 Embolization Particle Sales Channels
7.4.2 Embolization Particle Distributors
7.5 Embolization Particle Customer Analysis
8 Embolization Particle Market Dynamics
8.1 Embolization Particle Industry Trends
8.2 Embolization Particle Market Drivers
8.3 Embolization Particle Market Challenges
8.4 Embolization Particle Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Embolization Particle Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Embolization Particle Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Embolization Particle Market Competitive Situation by Manufacturers in 2025
Table 4. Global Embolization Particle Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Embolization Particle Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Embolization Particle Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Embolization Particle Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Embolization Particle Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Embolization Particle, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Embolization Particle, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Embolization Particle, Product Types and Applications
Table 12. Global Key Manufacturers of Embolization Particle, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Embolization Particle Companies by Tier (Tier 1, Tier 2, Tier 3), based on Embolization Particle Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Embolization Particle Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Embolization Particle Sales by Region (K Units), 2021–2026
Table 18. Global Embolization Particle Sales Market Share by Region (2021–2026)
Table 19. Global Embolization Particle Sales by Region (K Units), 2027–2032
Table 20. Global Embolization Particle Sales Market Share by Region (2027–2032)
Table 21. Global Embolization Particle Revenue by Region (US$ Million), 2021–2026
Table 22. Global Embolization Particle Revenue Market Share by Region (2021–2026)
Table 23. Global Embolization Particle Revenue by Region (US$ Million), 2027–2032
Table 24. Global Embolization Particle Revenue Market Share by Region (2027–2032)
Table 25. North America Embolization Particle Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Embolization Particle Sales by Country (K Units), 2021–2026
Table 27. North America Embolization Particle Sales by Country (K Units), 2027–2032
Table 28. North America Embolization Particle Revenue by Country (US$ Million), 2021–2026
Table 29. North America Embolization Particle Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Embolization Particle Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Embolization Particle Sales by Country (K Units), 2021–2026
Table 32. Europe Embolization Particle Sales by Country (K Units), 2027–2032
Table 33. Europe Embolization Particle Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Embolization Particle Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Embolization Particle Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Embolization Particle Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Embolization Particle Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Embolization Particle Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Embolization Particle Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Embolization Particle Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Embolization Particle Sales by Country (K Units), 2021–2026
Table 42. Latin America Embolization Particle Sales by Country (K Units), 2027–2032
Table 43. Latin America Embolization Particle Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Embolization Particle Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Embolization Particle Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Embolization Particle Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Embolization Particle Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Embolization Particle Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Embolization Particle Revenue by Country (US$ Million), 2027–2032
Table 50. Global Embolization Particle Sales (K Units) by Type (2021–2026)
Table 51. Global Embolization Particle Sales (K Units) by Type (2027–2032)
Table 52. Global Embolization Particle Sales Market Share by Type (2021–2026)
Table 53. Global Embolization Particle Sales Market Share by Type (2027–2032)
Table 54. Global Embolization Particle Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Embolization Particle Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Embolization Particle Revenue Market Share by Type (2021–2026)
Table 57. Global Embolization Particle Revenue Market Share by Type (2027–2032)
Table 58. Global Embolization Particle Price (USD/Unit) by Type (2021–2026)
Table 59. Global Embolization Particle Price (USD/Unit) by Type (2027–2032)
Table 60. Global Embolization Particle Sales (K Units) by Application (2021–2026)
Table 61. Global Embolization Particle Sales (K Units) by Application (2027–2032)
Table 62. Global Embolization Particle Sales Market Share by Application (2021–2026)
Table 63. Global Embolization Particle Sales Market Share by Application (2027–2032)
Table 64. Global Embolization Particle Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Embolization Particle Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Embolization Particle Revenue Market Share by Application (2021–2026)
Table 67. Global Embolization Particle Revenue Market Share by Application (2027–2032)
Table 68. Global Embolization Particle Price (USD/Unit) by Application (2021–2026)
Table 69. Global Embolization Particle Price (USD/Unit) by Application (2027–2032)
Table 70. Sirtex Medical Company Information
Table 71. Sirtex Medical Description and Business Overview
Table 72. Sirtex Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. Sirtex Medical Embolization Particle Product
Table 74. Sirtex Medical Recent Developments/Updates
Table 75. Merit Medical Company Information
Table 76. Merit Medical Description and Business Overview
Table 77. Merit Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. Merit Medical Embolization Particle Product
Table 79. Merit Medical Recent Developments/Updates
Table 80. Cook Medical Company Information
Table 81. Cook Medical Description and Business Overview
Table 82. Cook Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. Cook Medical Embolization Particle Product
Table 84. Cook Medical Recent Developments/Updates
Table 85. BTG Medical Company Information
Table 86. BTG Medical Description and Business Overview
Table 87. BTG Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. BTG Medical Embolization Particle Product
Table 89. BTG Medical Recent Developments/Updates
Table 90. Boston Scientific Corporation Company Information
Table 91. Boston Scientific Corporation Description and Business Overview
Table 92. Boston Scientific Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. Boston Scientific Corporation Embolization Particle Product
Table 94. Boston Scientific Corporation Recent Developments/Updates
Table 95. Terumo Corporation Company Information
Table 96. Terumo Corporation Description and Business Overview
Table 97. Terumo Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. Terumo Corporation Embolization Particle Product
Table 99. Terumo Corporation Recent Developments/Updates
Table 100. HENGRUI Medical Company Information
Table 101. HENGRUI Medical Description and Business Overview
Table 102. HENGRUI Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. HENGRUI Medical Embolization Particle Product
Table 104. HENGRUI Medical Recent Developments/Updates
Table 105. INterface BIOmaterials B.V. Company Information
Table 106. INterface BIOmaterials B.V. Description and Business Overview
Table 107. INterface BIOmaterials B.V. Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. INterface BIOmaterials B.V. Embolization Particle Product
Table 109. INterface BIOmaterials B.V. Recent Developments/Updates
Table 110. Alicon Company Information
Table 111. Alicon Description and Business Overview
Table 112. Alicon Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 113. Alicon Embolization Particle Product
Table 114. Alicon Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Embolization Particle Distributors List
Table 118. Embolization Particle Customers List
Table 119. Embolization Particle Market Trends
Table 120. Embolization Particle Market Drivers
Table 121. Embolization Particle Market Challenges
Table 122. Embolization Particle Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Embolization Particle
Figure 2. Global Embolization Particle Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Embolization Particle Market Share by Type: 2025 & 2032
Figure 4. Microspheres Product Picture
Figure 5. Particles (e.g. PVA Particles, Gelfoam Particles) Product Picture
Figure 6. Drug-eluting Beads (DEBs) Product Picture
Figure 7. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Product Picture
Figure 8. Global Embolization Particle Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Embolization Particle Market Share by Application: 2025 & 2032
Figure 10. Uterine Fibroid Embolization
Figure 11. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Figure 12. Liver Tumor Embolization
Figure 13. Trauma Embolization
Figure 14. Others
Figure 15. Global Embolization Particle Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Embolization Particle Market Size (US$ Million), 2021–2032
Figure 17. Global Embolization Particle Sales (K Units), 2021–2032
Figure 18. Global Embolization Particle Average Price (USD/Unit), 2021–2032
Figure 19. Embolization Particle Report Years Considered
Figure 20. Embolization Particle Sales Share by Manufacturers in 2025
Figure 21. Global Embolization Particle Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global Embolization Particle Players: Market Share by Revenue in Embolization Particle in 2025
Figure 23. Embolization Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global Embolization Particle Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America Embolization Particle Sales Market Share by Country (2021–2032)
Figure 26. North America Embolization Particle Revenue Market Share by Country (2021–2032)
Figure 27. U.S. Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe Embolization Particle Sales Market Share by Country (2021–2032)
Figure 30. Europe Embolization Particle Revenue Market Share by Country (2021–2032)
Figure 31. Germany Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific Embolization Particle Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific Embolization Particle Revenue Market Share by Region (2021–2032)
Figure 38. China Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Taiwan Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Indonesia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Thailand Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Malaysia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Philippines Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Latin America Embolization Particle Sales Market Share by Country (2021–2032)
Figure 49. Latin America Embolization Particle Revenue Market Share by Country (2021–2032)
Figure 50. Mexico Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Brazil Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Argentina Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Middle East and Africa Embolization Particle Sales Market Share by Country (2021–2032)
Figure 54. Middle East and Africa Embolization Particle Revenue Market Share by Country (2021–2032)
Figure 55. Turkey Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Saudi Arabia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. U.A.E Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Global Sales Market Share of Embolization Particle by Type (2021–2032)
Figure 59. Global Revenue Market Share of Embolization Particle by Type (2021–2032)
Figure 60. Global Embolization Particle Price (USD/Unit) by Type (2021–2032)
Figure 61. Global Sales Market Share of Embolization Particle by Application (2021–2032)
Figure 62. Global Revenue Market Share of Embolization Particle by Application (2021–2032)
Figure 63. Global Embolization Particle Price (USD/Unit) by Application (2021–2032)
Figure 64. Embolization Particle Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Embolization Particle Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Embolization Particle Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Embolization Particle Market Competitive Situation by Manufacturers in 2025
Table 4. Global Embolization Particle Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Embolization Particle Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Embolization Particle Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Embolization Particle Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Embolization Particle Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Embolization Particle, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Embolization Particle, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Embolization Particle, Product Types and Applications
Table 12. Global Key Manufacturers of Embolization Particle, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Embolization Particle Companies by Tier (Tier 1, Tier 2, Tier 3), based on Embolization Particle Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Embolization Particle Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Embolization Particle Sales by Region (K Units), 2021–2026
Table 18. Global Embolization Particle Sales Market Share by Region (2021–2026)
Table 19. Global Embolization Particle Sales by Region (K Units), 2027–2032
Table 20. Global Embolization Particle Sales Market Share by Region (2027–2032)
Table 21. Global Embolization Particle Revenue by Region (US$ Million), 2021–2026
Table 22. Global Embolization Particle Revenue Market Share by Region (2021–2026)
Table 23. Global Embolization Particle Revenue by Region (US$ Million), 2027–2032
Table 24. Global Embolization Particle Revenue Market Share by Region (2027–2032)
Table 25. North America Embolization Particle Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Embolization Particle Sales by Country (K Units), 2021–2026
Table 27. North America Embolization Particle Sales by Country (K Units), 2027–2032
Table 28. North America Embolization Particle Revenue by Country (US$ Million), 2021–2026
Table 29. North America Embolization Particle Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Embolization Particle Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Embolization Particle Sales by Country (K Units), 2021–2026
Table 32. Europe Embolization Particle Sales by Country (K Units), 2027–2032
Table 33. Europe Embolization Particle Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Embolization Particle Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Embolization Particle Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Embolization Particle Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Embolization Particle Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Embolization Particle Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Embolization Particle Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Embolization Particle Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Embolization Particle Sales by Country (K Units), 2021–2026
Table 42. Latin America Embolization Particle Sales by Country (K Units), 2027–2032
Table 43. Latin America Embolization Particle Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Embolization Particle Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Embolization Particle Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Embolization Particle Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Embolization Particle Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Embolization Particle Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Embolization Particle Revenue by Country (US$ Million), 2027–2032
Table 50. Global Embolization Particle Sales (K Units) by Type (2021–2026)
Table 51. Global Embolization Particle Sales (K Units) by Type (2027–2032)
Table 52. Global Embolization Particle Sales Market Share by Type (2021–2026)
Table 53. Global Embolization Particle Sales Market Share by Type (2027–2032)
Table 54. Global Embolization Particle Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Embolization Particle Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Embolization Particle Revenue Market Share by Type (2021–2026)
Table 57. Global Embolization Particle Revenue Market Share by Type (2027–2032)
Table 58. Global Embolization Particle Price (USD/Unit) by Type (2021–2026)
Table 59. Global Embolization Particle Price (USD/Unit) by Type (2027–2032)
Table 60. Global Embolization Particle Sales (K Units) by Application (2021–2026)
Table 61. Global Embolization Particle Sales (K Units) by Application (2027–2032)
Table 62. Global Embolization Particle Sales Market Share by Application (2021–2026)
Table 63. Global Embolization Particle Sales Market Share by Application (2027–2032)
Table 64. Global Embolization Particle Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Embolization Particle Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Embolization Particle Revenue Market Share by Application (2021–2026)
Table 67. Global Embolization Particle Revenue Market Share by Application (2027–2032)
Table 68. Global Embolization Particle Price (USD/Unit) by Application (2021–2026)
Table 69. Global Embolization Particle Price (USD/Unit) by Application (2027–2032)
Table 70. Sirtex Medical Company Information
Table 71. Sirtex Medical Description and Business Overview
Table 72. Sirtex Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. Sirtex Medical Embolization Particle Product
Table 74. Sirtex Medical Recent Developments/Updates
Table 75. Merit Medical Company Information
Table 76. Merit Medical Description and Business Overview
Table 77. Merit Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. Merit Medical Embolization Particle Product
Table 79. Merit Medical Recent Developments/Updates
Table 80. Cook Medical Company Information
Table 81. Cook Medical Description and Business Overview
Table 82. Cook Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. Cook Medical Embolization Particle Product
Table 84. Cook Medical Recent Developments/Updates
Table 85. BTG Medical Company Information
Table 86. BTG Medical Description and Business Overview
Table 87. BTG Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. BTG Medical Embolization Particle Product
Table 89. BTG Medical Recent Developments/Updates
Table 90. Boston Scientific Corporation Company Information
Table 91. Boston Scientific Corporation Description and Business Overview
Table 92. Boston Scientific Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. Boston Scientific Corporation Embolization Particle Product
Table 94. Boston Scientific Corporation Recent Developments/Updates
Table 95. Terumo Corporation Company Information
Table 96. Terumo Corporation Description and Business Overview
Table 97. Terumo Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. Terumo Corporation Embolization Particle Product
Table 99. Terumo Corporation Recent Developments/Updates
Table 100. HENGRUI Medical Company Information
Table 101. HENGRUI Medical Description and Business Overview
Table 102. HENGRUI Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. HENGRUI Medical Embolization Particle Product
Table 104. HENGRUI Medical Recent Developments/Updates
Table 105. INterface BIOmaterials B.V. Company Information
Table 106. INterface BIOmaterials B.V. Description and Business Overview
Table 107. INterface BIOmaterials B.V. Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. INterface BIOmaterials B.V. Embolization Particle Product
Table 109. INterface BIOmaterials B.V. Recent Developments/Updates
Table 110. Alicon Company Information
Table 111. Alicon Description and Business Overview
Table 112. Alicon Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 113. Alicon Embolization Particle Product
Table 114. Alicon Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Embolization Particle Distributors List
Table 118. Embolization Particle Customers List
Table 119. Embolization Particle Market Trends
Table 120. Embolization Particle Market Drivers
Table 121. Embolization Particle Market Challenges
Table 122. Embolization Particle Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Embolization Particle
Figure 2. Global Embolization Particle Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Embolization Particle Market Share by Type: 2025 & 2032
Figure 4. Microspheres Product Picture
Figure 5. Particles (e.g. PVA Particles, Gelfoam Particles) Product Picture
Figure 6. Drug-eluting Beads (DEBs) Product Picture
Figure 7. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Product Picture
Figure 8. Global Embolization Particle Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Embolization Particle Market Share by Application: 2025 & 2032
Figure 10. Uterine Fibroid Embolization
Figure 11. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Figure 12. Liver Tumor Embolization
Figure 13. Trauma Embolization
Figure 14. Others
Figure 15. Global Embolization Particle Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Embolization Particle Market Size (US$ Million), 2021–2032
Figure 17. Global Embolization Particle Sales (K Units), 2021–2032
Figure 18. Global Embolization Particle Average Price (USD/Unit), 2021–2032
Figure 19. Embolization Particle Report Years Considered
Figure 20. Embolization Particle Sales Share by Manufacturers in 2025
Figure 21. Global Embolization Particle Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global Embolization Particle Players: Market Share by Revenue in Embolization Particle in 2025
Figure 23. Embolization Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global Embolization Particle Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America Embolization Particle Sales Market Share by Country (2021–2032)
Figure 26. North America Embolization Particle Revenue Market Share by Country (2021–2032)
Figure 27. U.S. Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe Embolization Particle Sales Market Share by Country (2021–2032)
Figure 30. Europe Embolization Particle Revenue Market Share by Country (2021–2032)
Figure 31. Germany Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific Embolization Particle Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific Embolization Particle Revenue Market Share by Region (2021–2032)
Figure 38. China Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Taiwan Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Indonesia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Thailand Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Malaysia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Philippines Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Latin America Embolization Particle Sales Market Share by Country (2021–2032)
Figure 49. Latin America Embolization Particle Revenue Market Share by Country (2021–2032)
Figure 50. Mexico Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Brazil Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Argentina Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Middle East and Africa Embolization Particle Sales Market Share by Country (2021–2032)
Figure 54. Middle East and Africa Embolization Particle Revenue Market Share by Country (2021–2032)
Figure 55. Turkey Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Saudi Arabia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. U.A.E Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Global Sales Market Share of Embolization Particle by Type (2021–2032)
Figure 59. Global Revenue Market Share of Embolization Particle by Type (2021–2032)
Figure 60. Global Embolization Particle Price (USD/Unit) by Type (2021–2032)
Figure 61. Global Sales Market Share of Embolization Particle by Application (2021–2032)
Figure 62. Global Revenue Market Share of Embolization Particle by Application (2021–2032)
Figure 63. Global Embolization Particle Price (USD/Unit) by Application (2021–2032)
Figure 64. Embolization Particle Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Ethylene Oxide (EO) Market Research Report 2026
Jan 17, 26
Global Stem Cells Cryopreservation Equipments Market Research Report 2026
Jan 17, 26
Global Selenium-enriched Yeast Market Research Report 2026
Jan 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232